Format

Send to:

Choose Destination
See comment in PubMed Commons below
Bone Marrow Transplant. 1998 Jan;21(1):97-9.

Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation.

Author information

  • 1Washington University School of Medicine, Department of Internal Medicine, Division of Bone Marrow Transplantation, St Louis, MO 63110, USA.

Abstract

Conventional approaches to the treatment of recurrent mantle cell lymphoma (MCL) yield unsatisfactory results. We describe a patient with recurrent MCL in leukemic phase refractory to chemotherapy who was successfully treated with allogeneic bone marrow transplantation. At last follow-up 1 year post-transplant, the patient was in complete remission and had limited chronic graft-versus-host disease.

PMID:
9486503
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for FindIt@Stanford
    Loading ...
    Write to the Help Desk